Rhode Island Statin Monitoring Rates Have Lagged
Rhode Island clinicians missed cholesterol checks in 29% of visits for patients taking statins.
Updated on Oct. 5, 2026 in Heart Disease
Live Poll
Do you trust your local doctors to consistently monitor your health metrics?
A recent analysis revealed that Rhode Island clinicians failed to monitor cholesterol levels in 29% of primary care office visits for patients on statin therapy. This rate is significantly higher than the national average of 17%.
Why it matters
Routine monitoring is essential to ensure that statin therapy effectively manages lipid levels and reduces heart disease risk. Gaps in care can result in suboptimal treatment and contribute to the $105.8 billion annual cost of medication nonadherence in the U.S. health system.
Using the Practicing Wisely clinical analytics system, researchers examined 111,000 primary care office visits nationwide. The analysis identified that Rhode Island had the third-highest rate of unmonitored cholesterol among patients taking statins.
The players
Practicing Wisely
A clinical analytics system used to evaluate healthcare delivery and provider performance metrics.
The details
The analysis tracked whether clinicians performed routine cholesterol checks during standard primary care visits for patients prescribed statins. Regular testing is required to adjust dosages and ensure the medication reaches its therapeutic target for cardiovascular health. Monitoring failures across the country ranged from 14% in states like South Carolina and Texas to as high as 32% in Wyoming.
Timeline
September 29, 2026: Study results were released.
Health Landscape
This study underscores gaps in clinical care that hinder the effective use of statins for heart disease prevention. It highlights a critical disparity in monitoring standards that persists despite the massive economic burden of medication nonadherence in the United States.
If you are currently taking a statin, verify that your physician has a routine schedule for checking your cholesterol levels. It is worth discussing with your doctor how often you should be tested to ensure your treatment remains effective.
The takeaway
Consistent monitoring is vital for anyone managing heart disease risk through statin therapy. Always confirm your follow-up testing schedule during your next primary care visit.
Further reading
For more information on managing lipid levels, visit the Heart Disease section.
Source note: This article includes information reported by Providence Business News.
Live Poll
Do you trust your local doctors to consistently monitor your health metrics?
